Palomar Medical Technologies Inc  

(Public, NASDAQ:PMTI)   Watch this stock  
Find more results for PMTI
Jun 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 7.06 - 13.97
Open     -
Vol / Avg. 0.00/128,366.00
Mkt cap 267.90M
P/E     -
Div/yield     -
EPS -0.27
Shares     -
Beta 1.42
Inst. own     -

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin -4.79% -7.66%
Operating margin -4.04% -7.44%
EBITD margin - -5.61%
Return on average assets -2.63% -3.56%
Return on average equity -2.96% -4.04%
Employees 250 -
CDP Score - -


15 Network Drive
United States - Map
+1-781-9932300 (Phone)
+1-781-9932330 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Palomar Medical Technologies, Inc. (Palomar) is a researcher and developer of aesthetic light-based systems for hair removal and other cosmetic procedures, including both lasers and high powered lamps. The Company offers a range of products based on technologies that include, but are not limited to: hair removal; body sculpting, including laser-assisted liposuction; removal of vascular lesions, such as rosacea, spider veins, port wine stains and hemangiomas; wrinkle reduction; removal of leg veins; removal of benign pigmented lesions, such as age and sun spots, freckles and melasma; tattoo removal; acne treatment; skin resurfacing, pseudofolliculitis barbae (PFB) treatment; treatment of red pigmentation in hypertrophic and keloid scars; treatment of verrucae, skin tags and seborrheic keratosis; skin tightening through soft tissue coagulation; scars, and other skin treatments. In June 2013, Cynosure Inc announced the completion of its acquisition of Palomar Medical Technologies Inc.